
Adam S Fleisher MD MAS
Dementia & Geriatrics
Associate Vice President - Neuroscience
Join to view full profile
893 Delaware stIndianapolis, IN 46225
Phone+1 317-653-0370
Dr. Fleisher is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Johns Hopkins UniversityResidency, Neurology, 1999 - 2002
Johns Hopkins UniversityInternship, Internal Medicine, 1998 - 1999
University of Rochester School of Medicine and DentistryClass of 1998
Certifications & Licensure
AZ State Medical License 2008 - 2027
IN State Medical License 2018 - 2027
CA State Medical License 2002 - 2015
American Board of Psychiatry and Neurology Neurology
Publications & Presentations
PubMed
- 2 citationsTau biology, biomarkers, and therapeutics.Bess Frost, Hartmuth Kolb, Alicia Algeciras-Schimnich, Tobey J Betthauser, Sarah DeVos
Alzheimer's & Dementia. 2025-10-21 - 21 citationsDiscovery and clinical translation of ceperognastat, an O-GlcNAcase (OGA) inhibitor, for the treatment of Alzheimer's disease.William Kielbasa, Paul Goldsmith, Kevin B Donnelly, Hugh N Nuthall, Sergey Shcherbinin
Alzheimer's & Dementia. 2024-12-26 - 3 citationsAlzheimer's disease drug development in an evolving therapeutic landscape.Stacie Weninger, Michael C Irizarry, Adam S Fleisher, Teresa León, Paul Maruff
Alzheimer's & Dementia. 2024-11-30
Journal Articles
- Aggregated Tau Measured by Visual Interpretation of Flortaucipir Positron Emission Tomography and the Associated Risk of Clinical Progression of Mild Cognitive Impairm...Adam Fleisher, MD, JAMA Neurology
Press Mentions
Alzheimer's Pathology, Tangles Predicted by Tau PETApril 27th, 2020
Associations of Regional Brain Structural Differences with Aging, Modifiable Risk Factors for Dementia, and Cognitive PerformanceDecember 2nd, 2019
Association of Altered Liver Enzymes with AD, Cognition, Neuroimaging Measures, and Cerebrospinal Fluid BiomarkersJuly 31st, 2019
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









